(COLD SPRING HARBOR, N.Y.) -- A new study identifies the first ever possible target therapy approach for liver cancer.
The authors of the study –- conducted by Cold Spring Harbor Laboratory and published in the journal Cancer Cell –- identified a gene that is overactive in 15 percent of liver cancers. Experiments in mice showed that shutting down this gene with a drug led to tumor shrinkage.
Researchers believe that this is a promising target for liver cancer treatment and can be tested in humans.
Copyright 2011 ABC News Radio